And expect an earnings upgrade in the next week or two:"With the recent acquisitions the company expects to provide the market with revised pro-formaestimates over coming weeks."
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025